Risk of malignancy associated with cyclosporin use in psoriasis

Dermatology. 1999;198(3):320-1. doi: 10.1159/000018142.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Cyclosporine / adverse effects*
  • Cyclosporine / therapeutic use
  • Dermatologic Agents / adverse effects*
  • Dermatologic Agents / therapeutic use
  • Humans
  • Neoplasms / chemically induced*
  • Psoriasis / drug therapy*
  • Risk Factors

Substances

  • Dermatologic Agents
  • Cyclosporine